Latest News about AZN
Recent news which mentions AZN
PR Agency Tells Blue-Chip Clients Like AT&T, Coca-Cola, Netflix And More To Avoid Media Inquiries On Abortion Debate
May 06, 2022
From Benzinga
3 Top Biotech Stocks to Buy Right Now
May 06, 2022
From Motley Fool
3 Nasdaq 100 Stocks to Buy Hand Over Fist in May
May 06, 2022
From Motley Fool
FDA Approval For AstraZeneca - Daiichi's Enhertu Expands To Earlier Use In Metastatic Breast Cancer
May 05, 2022
From Benzinga
From Benzinga
From Benzinga
FDA Accepts AstraZeneca's sBLA for Imfinzi (durvalumab) in biliary tract cancer (BTC) with Priority Review
May 04, 2022
From Benzinga
From Benzinga
From Benzinga
1 Top Dividend Stock to Buy and Hold Forever
May 01, 2022
From Motley Fool
Read Why This Analyst Is 'Encouraged' By Seagen's Q1 Sales
April 29, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For April 29, 2022
April 29, 2022
From Benzinga
Pandemic is not over yet, says Dr. Fauci, and WHO says omicron accounted for 99.7% of all cases sequenced in latest week
April 28, 2022
From MarketWatch
From Benzinga
From Benzinga
Daiichi Sankyo - AstraZeneca's Enhertu Receives Third Breakthrough Therapy Tag In Breast Cancer
April 27, 2022
From Benzinga
From Benzinga
3 Biotech Stocks Under $10 to Add to Your Buy List
April 26, 2022
From InvestorPlace
From MarketWatch
Valneva Receives More Questions From European Regulator For Its COVID-19 Vaccine, Shares Fall
April 25, 2022
From Benzinga
AstraZeneca's Tremelimumab/Imfinzi Combo Regime Goes Under Priority FDA Review For Liver Cancer
April 25, 2022
From Benzinga
From Motley Fool
2 Dividend Stocks to Buy and Hold Forever
April 22, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.